Centre Hospitalier de la Dracénie
About Centre Hospitalier de la Dracénie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Federation Francophone de Cancerologie Digestive
3
Groupe Oncologie Radiotherapie Tete et Cou
3
Hoffmann-La Roche
3
Intergroupe Francophone de Cancerologie Thoracique
3
ARCAGY/ GINECO GROUP
2
French Society for Intensive Care
2
UNICANCER
2
AGO Research GmbH
1
Association Sud pour la Recherche en Oncogériatrie
1
Centre Francois Baclesse
1
Centre Hospitalier Intercommunal Creteil
1
Clinical Trials at Centre Hospitalier de la Dracénie
During the past decade, Centre Hospitalier de la Dracénie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Women With Stage I Breast Cancer
2002-08-01
2013-06-01
Completed
1,512
Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
2005-10-01
2012-03-01
Completed
202
Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery
2008-02-01
2014-09-01
Completed
820
Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer
2009-09-01
2021-06-01
Completed
1,997
Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments
2010-01-01
2014-07-01
Completed
490
Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol
2010-06-01
2011-11-01
Completed
130
Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
2009-09-01
2014-01-01
Completed
54
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre Hospitalier de la Dracénie" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 3 trials, followed by "Groupe Oncologie Radiotherapie Tete et Cou" with 3 trials
sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 3 trials sponsored and "ARCAGY/ GINECO GROUP"
with 3 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de la Dracénie"
#1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 3 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "UNICANCER" with 2 trials as a collaborator, "AIO-Studien-gGmbH" with 1 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Centre Hospitalier de la Dracénie
According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de la Dracénie" are
"Breast Cancer" (4 trials), "Colorectal Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Squamous Cell Head and Neck Carcinoma" (2 trials) and "ALK Gene Mutation" (1 trials). Many other conditions were trialed in "Centre Hospitalier de la Dracénie" in a lesser frequency.
Clinical Trials Intervention Types at Centre Hospitalier de la Dracénie
Most popular intervention types in "Centre Hospitalier de la Dracénie" are "Drug" (16 trials), "Other" (4 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (3 trials), "Cisplatin" (3 trials), "Cetuximab" (2 trials), "Pemetrexed" (2 trials) and "fluorouracil" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centre Hospitalier de la Dracénie
The vast majority of trials in "Centre Hospitalier de la Dracénie" are
20 trials for "All" genders and 6 trials for "Female" genders.
Clinical Trials Status at Centre Hospitalier de la Dracénie
Currently, there are NaN active trials in "Centre Hospitalier de la Dracénie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in Centre Hospitalier de la Dracénie,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Centre Hospitalier de la Dracénie, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".